Health X Platform Ltd.
Fundamentals
- Market cap
- ₹1,044 cr
- P/E
- 887.88×
- ROE
- 0.00%
- Debt / equity
- 0.00
- 52-week range
- 252.50 — 363.00
Analysis — the numbers vs the call
- Health X's record quarter masks strategy reversals on debt and branded-generic conflict
Revenue hits ₹400 cr in Q1, but management's about-face on capital and channel conflict undercut the FY30 vision
Health X Platform Ltd.
Latest quarter · Mar 2026
Leverage & growth
The timeline — 5 notes on Health X Platform Ltd.
June 2026
- 19 Jun 26 · 1:50 PM IST Brief Brief · Earnings · Small cap
Health X transcript confirms FY30 revenue target of ₹6,000 cr
The Q4 FY26 earnings call transcript, published June 19, also details ₹234 cr capex and JITO private-label sales at ₹30 lakhs/month. No material new information beyond the earlier call.
- 12 Jun 26 · 5:15 PM IST Brief Brief · Earnings · Small cap
Health X targets ₹6,000 cr FY30 revenue, Q1 hits ₹400 cr
FY26 revenue rose 18% to ₹1,283 cr, EBITDA loss narrowed to ₹65 cr. Management targets 5x growth with ₹424 cr warehouse capex, partly debt-funded.
- 10 Jun 26 · 6:29 PM IST Lead Lead · Small cap
Health X splits its tiny finance arm, absorbs core healthcare unit into parent
A complex restructuring demerges a 1.1%-of-revenue financial business into a new listed entity while merging the much larger Sastasundar Healthbuddy drug-distribution unit back into the listed company.
- 05 Jun 26 · 5:42 PM IST Brief Brief · Small cap
Health X promoter sheds 0.79% stake for ₹7.5 cr
Ravi Kant Sharma sold 250,000 shares in an open-market transaction on June 3, cutting his holding to 2.35%. The sale is small relative to the company's ₹958 crore market cap.